Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma (NCT07236502)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this project is to evaluate the impact of a 16-week lifestyle program that promotes changes in eating and exercise patterns. The main questions the study will answer are: Do improvements in eating and exercise patterns lead to improved physical function, quality of life and blood biomarkers of biologial aging among individuals with multiple myeloma? Participants will complete study activities 3-4 times during the study. 1. In-person assessment to measure physical function, height/weight, body composition, and includes a blood draw 2. Surveys completed online or on paper at home
Who can join: Review the eligibility criteria below.
Location: Loyola University Chicago — Maywood, Illinois
Age range: 18 Years
🧪 Interventions in This Study
- Immediate intervention (BEHAVIORAL)
- Waitlist (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Loyola University Chicago — Maywood, Illinois
- Medical College of Wisconsin — Milwaukee, Wisconsin
📞 Contact the Study Coordinator
Phone: (312) 735-6044
Email: mstolley@mcw.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Multiple Myeloma (MM)
- Neurocognitive Trajectories After BCMA CAR-T — Charlotte, North Carolina
- MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma — Little Rock, Arkansas
- PET-Enabled Dual-Energy CT in Multiple Myeloma — Sacramento, California
- A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects — Gilbert, Arizona
- A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma — Denver, Colorado
Explore by condition: All Multiple Myeloma (MM) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.